What is the assay value?

The assay value is 100 Million cfu/g.

What are the lead times for production?

The average lead time is within 15 workdays for both peak and off-peak seasons.

Sost New Product Lactobacillus Paracasei Powder

Name: Sost New Product Lactobacillus Paracasei Powder
Brand: Xi an Sost Biotech Co., Ltd.
SKU: 2030681705

Shaanxi, ChinaXi an Sost Biotech Co., Ltd.

US$45.00-50.00

10 kg

Sample price:US$50.00/kg.Request sample

Product profile

Customization

Available

Storage Method

Normal

Shelf Life

>12 Months

Nutrient Composition

Mineral

Resource

Chemosynthesis

The content of active substances

＞90%

Transport Package

1.1 Kilogram Per Aluminum Foil Bag with One Plast

Specification

98.5%-101%

Trademark

SOST

Origin

China

Production Capacity

100 Kg/Momth

Key features

High Active Substance Content: Active substance content exceeds 90% for maximum efficacy.

Immune System Support: Boosts immune function and increases natural killer cell activity.

Anti-inflammatory Properties: Helps reduce symptoms of hay fever, eczema, and allergic rhinitis.

Digestive Health Improvement: Breaks down food, absorbs nutrients, and balances intestinal microbiota.

Long Shelf Life: Shelf life exceeds 12 months when stored under normal conditions.

High Purity Standard: 100 Million cfu/g assay with 100% pass rate on 80 mesh sieve.

Safety Compliance: Free from heavy metals, E. coli, and Salmonella; low residual solvents.

OEM and ODM Services: Customized manufacturing services available for dietary supplements.

Company profile

Xi an Sost Biotech Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2012-11-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.01h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an Sost Biotech Co., Ltd. is identified as a China-based manufacturer and trading company focused on herbal extracts, Chinese medicine raw materials, cosmetic ingredients, healthcare ingredients, food additives, and dietary supplement ingredients. Evidence indicates established production, R&D, sales, purchasing, and quality-control functions, with stated GMP-oriented operations, ISO 9001:2015 certification, multiple production bases, and broad export coverage. However, the records contain conflicting production information: one slice reports three production bases and eight lines, while another reports a 2,990 m² plant and two production lines. The supplier states that it provides pre- and after-sales service and accepts several trade and payment terms, but detailed service performance, customization results, customer references, and financial strength are not sufficiently documented. Monetary figures are omitted.

Supplier typeThe supplier is explicitly classified as a manufacturer and limited company, while another record identifies its business nature as a trading company. Its stated activities include R&D, production, sales, and service of herbal extracts and natural raw materials, so it appears to combine manufacturing and trading functions.

CertificationsThe supplier reports ISO 9001:2015 certification and states that production follows national GMP standards, with GMP-standard factories and 100,000-level clean workshops. ISO certification is explicit; the GMP statements are operational claims rather than a separately named certificate.

After-Sales capabilityThe company explicitly emphasizes before-sales and after-sales service, states that it continuously improves service, and describes service as part of its business operations. However, no evidence gives measurable after-sales performance, service staffing, response times, or documented customer outcomes.

R&D capabilityThe supplier reports an R&D department, research and development of high-purity natural products, biological engineering and natural extraction technology, and an innovation-oriented approach. Nevertheless, only two years of R&D engineer experience are reported, and there is no evidence of patents, new-product records, or quantified R&D achievements.

Production capacityProduction capability is supported by a stated manufacturing plant, natural-extract production activities, GMP-oriented facilities, clean workshops, and product lines covering food, healthcare, cosmetics, and pharmaceutical intermediates. The data are inconsistent: one record states three production bases and eight lines, while another reports a 2,990 m² plant and two lines; quality-control staffing is also reported as fewer than five employees.